Can a DNA-Enriched mouthwash tame gum disease biofilm?

NCT ID NCT06028867

First seen Aug 07, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This trial tests whether a mouthwash containing chlorhexidine and sodium DNA can better control bacterial biofilm in people with advanced periodontitis (stage III or IV). Participants will receive standard non-surgical gum treatment plus one of two mouthwashes or a placebo, and researchers will compare their effects on subgingival biofilm after two weeks. The goal is to see if the sodium DNA formulation offers extra antimicrobial benefits over chlorhexidine alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Chlorhexidine 0.12% + Sodium DNA mouthwash
What this could lead to
If effective, this mouthwash could become a simple at-home addition to gum disease treatment, helping to control bacterial biofilm and improve outcomes.
What could go wrong
This is a small, early-stage trial, so results may not be conclusive or widely applicable. The mouthwash may not outperform standard care, and side effects like tooth staining are possible with chlorhexidine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AOU Policlinico G. Rodolico

    Catania, Italy, 95124, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.